GSC The List

Post Reply
Forum Home > M > MULTIPLE SCLEROSIS / MS*+ (2013-2015)

[email protected]
Site Owner
Posts: 1174

Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report (full – 2013) http/

Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis. (full – 2013) http/

Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis (full – 2013) http/

Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis (full – 2013) http/

Therapeutic potential of cannabinoid medicines. (full – 2013) http/

Multiple sclerosis and the blood-central nervous system barrier. (full – 2013) http/

A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK. (full – 2013) http/

Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients (full – 2013) http/

Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors. (full – 2013) http/

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis. (full – 2013) http/

Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis. (full – 2013) http/

Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain. (abst – 2013) http/

Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors. (abst – 2013) http/

Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain. (abst – 2013) http/

Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review. (abst – 2013) http/

Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration (abst – 2013) http/

Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype. (abst – 2013) http/

Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists. (abst – 2013) http/

Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis. (abst – 2013) http/

Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice. (abst – 2013) http/

Still Believe Nature Got It Wrong? Top 10 Health Benefits of Marijuana (news – 2013) http/

Research shows marijuana can be effectively used to treat multiple sclerosis (news – 2013) http/

Medical Marijuana: Consortium of Multiple Sclerosis Centers (news – 2013) http/

Aylsham multiple sclerosis sufferer says cannabis-based drug ‘changed my life’ (news – 2013) http/

Multiple Sclerosis and Cannabis - A Conversation With Clark French (news – 2013) http/

Sending multiple sclerosis up in smoke (news – 2013) http/

Chemicals in marijuana 'protect nervous system' against MS (news – 2013) http/

Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. (full – 2014) http/

Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience. (full – 2014) http/

THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies. (full – 2014) http/

Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis (full – 2014) http/

Docosahexaenoyl ethanolamide improves glucose uptake and alters endocannabinoid system gene expression in proliferating and differentiating C2C12 myoblasts. (full – 2014) http/

The endocannabinoid system: a putative role in neurodegenerative diseases. (full – 2014) http/

Current and future drugs for treatment of MS-associated bladder dysfunction. (full – 2014) http/

Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosisrelated spasticity. (abst – 2014) http/

Nabiximols (THC/CBD Oromucosal Spray, Sativex® in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity. (abst – 2014) http/

Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®: A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis. (abst – 2014) http/

Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis. (abst – 2014) http/

Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice. (abst – 2014) http/

Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental l-DOPA-induced dyskinesia (abst – 2014) http/

Study uncovers marijuana's potential to treat autoimmune diseases (news – 2014) http/

Marijuana Benefits MS Patients as Other Remedies Fail (news – 2014) http/

Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation (full – 2015)

Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full – 2015)

Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients (full – 2015)

Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial (full – 2015)

Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability (full – 2015)

Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst – 2015)

Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice (abst – 2015)

March 16, 2015 at 11:41 PM Flag Quote & Reply

This topic is closed, no additional posts are allowed.